We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

iCo Therapeutics Completes iCo-007 Phase 2 Clinical Supply Manufacturing

News   Feb 23, 2011

 
iCo Therapeutics Completes iCo-007 Phase 2 Clinical Supply Manufacturing
 
 
Advertisement
 

RELATED ARTICLES

Molecular Switch Turns on Brown Fat Energy Burn

News

An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity.

READ MORE

How Cells Keep Growing Even When Under Attack

News

In an unexpected new finding, biochemists at the University of Massachusetts Amherst report observing that a damage-containment system in stressed bacteria can become overrun and blocked, but that this leads to cells responding by turning on very different pathways to make sure that normal growth continues.

READ MORE

Team Develops Synthetic Blood-Thinner With No Bleeding Side Effects

News

Scientists have developed a highly selective and highly stable synthetic blood-thinning molecule that, unlike others, doesn’t cause bleeding adverse effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE